BOB体育

Registration Now Open for June 7 Event in Maple Lawn Howard County

Marking its 17th year, the Maryland Half Marathon & 5K returns to the Maple Lawn community in Howard County on Saturday, June 7, 2025. This signature event empowers runners, walkers, and fundraisers to join forces against cancer, driving critical support for the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). Since 2009, the Maryland Half Marathon & 5K has raised over $6 million, fueling groundbreaking research and compassionate patient care.

Participants can choose between the 13.1-mile half marathon and the 5K race/walk. Registration is $75 for the half marathon and $40 for the 5K through Thursday, June 5; fees increase on Friday, June 6, when registration closes at 9 p.m. All registered runners and walkers receive an official race T-shirt, medal, and access to a personalized training and fundraising dashboard.

“Each year, it’s incredible to witness how participants, volunteers, and donors unite to bring hope to those battling cancer,” said Michael Greenebaum, co-founder of the Maryland Half Marathon & 5K and a UMGCCC Board of Advisors member. “Through our collective efforts, we continue to push the boundaries of research and care, moving us closer to a future free from this disease.”

Race participants can use the free Good Move app to track their training miles, invite friends to donate, and stay motivated throughout their fundraising journey. Individuals who prefer not to run or walk can register free as fundraisers—with a minimum $5 self-donation required to access all fundraising tools—ensuring everyone can support the event’s $500,000 fundraising goal.

“The generous donations and engaged participation make our lifesaving work possible,” said Taofeek K. Owonikoko, MD, PhD, Executive Director of UMGCCC. “From developing cutting-edge therapies to providing comprehensive care, every dollar raised helps us bring new hope to cancer patients across Maryland and beyond.”

For more information or to register, visit . Proceeds benefit research and patient programs at UMGCCC, where expert teams work tirelessly to advance cancer treatment from the laboratory to the bedside.

This year’s event is made possible by the support of St. John Properties, Greenebaum Enterprises, Berkeley Research Group, LLC, Chesapeake Contracting Group, and a team of dedicated volunteers and participants. To learn more about UMGCCC, visit .

About UMGCCC

UMGCCC is one of two NCI-designated comprehensive cancer centers in Maryland and one of 57 in the United States. It offers innovative approaches to diagnosing and treating all types of cancer, conducts cutting-edge research to bring the latest advances in cancer treatment directly to patients and provides cancer screening and patient education services. The cancer center is nationally recognized for its excellence in patient care and multidisciplinary, translational research programs.

In recent years, UMGCCC has pioneered advances in cancer treatment, including:

• Development of aromatase inhibitors to treat breast cancer by the late Angela Brodie, PhD
• Invention of the GammaPod, a new radiation treatment option for early-stage breast cancer that can reduce the number of treatments and spare healthy tissue from radiation
• Development of promising new drug compounds and immunotherapies, such as a next-generation chimeric antigen receptor (CAR) T-cell therapy.